What We Do
We develop novel therapeutics to dramatically improve outcomes for cancer patients, using world-leading innovation in p27 biology
Featured In
01
BiotechTV: Stacy Blain is the Founder and CEO of Concarlo Therapeutics, which is the first company to target CDK4/6-driven cell proliferation and CDK2-driven resistance
02
Many startups are built off research, so why don’t more scientists become founders?
03
CDK Inhibitors: Why Women – and Men – Should Know About
This ‘New Era’ Of Cancer Treatment
04
The academic to founder pipeline with Dr. Stacy Blain from
Concarlo Therapeutics
05
FORCE Family:
Cancer Moonshoot Webinar
06
Drug Discovery World: US Biotech Start-up Set to Have Huge Impact on Breast Cancer Treatment Landscape
07
BioCentury: Concarlo: Targeting proliferation
and resistance in one go
Awards
“The reward for work well done is the opportunity to do more”
—Jonas Salk
Winner of 2025 TiE SoCal Women Founders
Pitch Competition
Top Therapeutic Company at Aquillius’ 2025 Innovation in Women’s Health Pitch Showcase
The 50 Most admired companies: CIO Bio
Top 100 entreprenuers: Alumni List
Top Biotech Startup 2022
Awarded by: Life Sciences Review
